Terug
71
Dagbereik
€ 82,00
€ 85,45
52-Weeksbereik
€ 74,52
€ 218,25
Volume
211
50D / 200D Gem.
€ 105,68
/
€ 163,67
Vorige Slotkoers
€ 85,66
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 77,5 | 0,4 |
| P/B | 34,7 | 2,9 |
| ROE % | 51,8 | 3,9 |
| Net Margin % | 54,1 | 3,8 |
| Rev Growth 5Y % | 33,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 155,00
+81.4%
Forward K/W
49,5
Forward WPA
€ 1,73
WPA Groei (sch.)
+0,0%
Omzet Sch.
290 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,00
€ 0,00 – € 0,00
|
540 M | 0 |
| FY2029 |
€ 3,62
€ 3,32 – € 3,90
|
600 M | 1 |
| FY2028 |
€ 2,49
€ 2,28 – € 2,68
|
470 M | 1 |
Belangrijkste Punten
Revenue grew 33,08% annually over 5 years — strong growth
Earnings grew 39,16% over the past year
ROE of 51,82% indicates high profitability
Net margin of 54,12% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 103,96M in free cash flow
Groei
Revenue Growth (5Y)
33,08%
Revenue (1Y)31,83%
Earnings (1Y)39,16%
FCF Growth (3Y)33,50%
Kwaliteit
Return on Equity
51,82%
ROIC45,60%
Net Margin54,12%
Op. Margin74,03%
Veiligheid
Debt / Equity
0,01
Current Ratio6,49
Interest Coverage0,00
Waardering
P/E Ratio
77,48
P/B Ratio34,74
EV/EBITDA55,55
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 31,83% | Revenue Growth (3Y) | 30,56% |
| Earnings Growth (1Y) | 39,16% | Earnings Growth (3Y) | 37,83% |
| Revenue Growth (5Y) | 33,08% | Earnings Growth (5Y) | 39,02% |
| Profitability | |||
| Revenue (TTM) | 212,91M | Net Income (TTM) | 115,22M |
| ROE | 51,82% | ROA | 34,02% |
| Gross Margin | 99,85% | Operating Margin | 74,03% |
| Net Margin | 54,12% | Free Cash Flow (TTM) | 103,96M |
| ROIC | 45,60% | FCF Growth (3Y) | 33,50% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 6,49 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 77,48 | P/B Ratio | 34,74 |
| P/S Ratio | 41,93 | PEG Ratio | 6,50 |
| EV/EBITDA | 55,55 | Dividend Yield | 0,00% |
| Market Cap | 8,93B | Enterprise Value | 8,75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 212,91M | 161,50M | 124,90M | 93,46M | 67,88M |
| Net Income | 115,22M | 82,79M | 60,65M | 44,44M | 30,85M |
| EPS (Diluted) | 1,10 | 0,79 | 0,58 | 0,43 | 0,30 |
| Gross Profit | 212,60M | 161,20M | 92,37M | 92,94M | 46,66M |
| Operating Income | 157,61M | 114,84M | 86,20M | 64,93M | 44,42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 338,70M | 257,43M | 202,14M | 157,05M | 125,57M |
| Total Liabilities | 81,74M | 69,70M | 63,36M | 55,32M | 43,89M |
| Shareholders' Equity | 256,96M | 187,73M | 138,78M | 101,73M | 81,68M |
| Total Debt | 2,26M | 2,07M | 1,85M | 2,28M | 2,62M |
| Cash & Equivalents | 174,54M | 60,06M | 91,25M | 63,66M | 42,04M |
| Current Assets | 280,09M | 206,56M | 163,79M | 119,82M | 87,57M |
| Current Liabilities | 43,14M | 34,56M | 30,85M | 26,86M | 17,62M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#47 of 157
Recente Activiteit
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026